FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/10/046558 [Registered on: 17/10/2022] Trial Registered Prospectively
Last Modified On: 28/12/2023
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Interpretive observational study 
Study Design  Other 
Public Title of Study   Program evaluation of hemophilia society activities 
Scientific Title of Study   Evaluation of support program extended to people with hemophilia: A multicentric mixed qualitative study 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Diksha D Shroff 
Designation  Ph.D Scholar 
Affiliation  Melaka Manipal Medical College (Manipal Campus) 
Address  Department of Pediatrics Melaka Manipal Medical College (Manipal Campus) Manipal Academy Of Higher education, Manipal Udupi KARNATAKA 576104 India

Udupi
KARNATAKA
576104
India 
Phone  9035192920  
Fax    
Email  dikshashroff10@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Dinesh M Nayak 
Designation  Professor and Head 
Affiliation  Melaka Manipal Medical College (Manipal Campus) 
Address  Department of Pediatrics Melaka Manipal Medical College (Manipal Campus) Manipal Academy Of Higher education, Manipal Udupi KARNATAKA 576104 India

Udupi
KARNATAKA
576104
India 
Phone  9845226437  
Fax    
Email  dinesh.nayak@manipal.edu  
 
Details of Contact Person
Public Query
 
Name  Dr Sreejith Govindan 
Designation  Deputy Registrar - Evaluation (Health Sciences), MAHE Associate Professor of Microbiology 
Affiliation  Melaka Manipal Medical College (Manipal Campus) 
Address  Melaka Manipal Medical College (Manipal Campus) Manipal - 576104

Udupi
KARNATAKA
576104
India 
Phone  9980959353  
Fax    
Email  g.sreejith@manipal.edu  
 
Source of Monetary or Material Support  
Manipal Academy of Higher Education, Manipal 
 
Primary Sponsor  
Name  NIL 
Address  NIL 
Type of Sponsor  Other [NIL] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sreejith G  Manipal hemophilia society   Kasturba hospital,Manipal -Opp to ENT OPD -4th floor,576104
Udupi
KARNATAKA 
9980959353

g.sreejith@manipal.edu 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Kasturba Medical college and kasturba Hospital Institutional ethics commitee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: D67||Hereditary factor IX deficiency, (2) ICD-10 Condition: D66||Hereditary factor VIII deficiency,  
 
Intervention / Comparator Agent  
Type  Name  Details 
 
Inclusion Criteria  
Age From  13.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  Persons with hemophilia, care givers (Mother, Fathers and close relatives) those associated for more than 2 years with the society, executive members of the chapters with >2 Years of experience as office bearer. 
 
ExclusionCriteria 
Details  Females who are diagnosed with hemophilia, PwH who are not a member of a chapter, parents who are not living with PwH, non-residents of India. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
The proposed study aims at exploring the day to day life and the impact of hemophiliacs being a part of the hemophilia society   16 months 
 
Secondary Outcome  
Outcome  TimePoints 
The evidence of the positive impacts made on the life of PwH and their family by the hemophilia society  12 months 
 
Target Sample Size   Total Sample Size="297"
Sample Size from India="297" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   24/10/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="3"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Hemophilia is an X-linked bleeding disorder, caused by an inherited deficiency of clotting factor VIII (hemophilia A) or factor IX (hemophilia B) which leads to spontaneous and posttraumatic bleeds. At present Indian hemophilia (Bleeding disorder) registry has close to 20,000 hemophilia patients all over the country, though we expect the number to swell near 85,000–1,00,000. People with hemophilia (PwH) and their families have diverse requirements and are best served by a multidisciplinary team of healthcare experts delivering coordinated, comprehensive care. Patient support programs are designed and implemented to provide personalized assistance and tailored interventions to improve patient health outcomes.

 

The purpose of the study is to:

·       Exploring the lived experiences of a PwH 

·       Assessing the impact of the hemophilia society in the day-to-day life of a PwH

·       To assess the positive impact made by the hemophilia society in a PwH

·       Exploring the nature of participation of stakeholders in the facilitation of the activities of the hemophilia society  

 

Methods: A multi method qualitative approach using in-depth interviews, focus group discussion and appreciative inquiry ,photo voice method(Photovoice is a qualitative, participatory, action-oriented data collection method whereby study participants use cameras to record their real-life experiences) will be conducted. The  interview will be audio recorded with prior consent from the participant.

 
Close